These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3058457)

  • 41. Initial site of insulin cleavage by insulin protease.
    Duckworth WC; Stentz FB; Heinemann M; Kitabchi AE
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):635-9. PubMed ID: 284388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes.
    Pell ME; Duckworth WC; Peavy DE
    Biochem Biophys Res Commun; 1986 Jun; 137(3):1034-40. PubMed ID: 3524565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of bacitracin on binding and processing of insulin by established renal cell line.
    Yagil C; Frank BH; Rabkin R
    Diabetes; 1988 Jun; 37(6):800-5. PubMed ID: 3290001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Processing of 125I-insulin by polarized cultured kidney cells.
    Rabkin R; Hamik A; Yagil C; Hamel FG; Duckworth WC; Fawcett J
    Exp Cell Res; 1996 Apr; 224(1):136-42. PubMed ID: 8612678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
    Zhou W; Li S; Deng S
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytes.
    Duckworth WC; Peavy DE; Hamel FG; Liepnieks J; Brunner MR; Heiney RE; Frank BH
    Biochem J; 1988 Oct; 255(1):277-84. PubMed ID: 2848505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin degradation in vivo: a high-performance liquid chromatographic analysis.
    Benzi L; Cecchetti P; Ciccarone AM; Di Cianni G; Iozzi LC; Caricato F; Navalesi R
    J Chromatogr; 1990 Dec; 534():37-46. PubMed ID: 2094722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA
    J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
    Pérez Maceda B; Linde S; Sonne O; Gliemann J
    Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of insulin proteolysis in rat liver endosomes: its relationship to intracellular insulin signaling.
    Authier F; Desbuquois B
    Methods Enzymol; 2014; 535():3-23. PubMed ID: 24377914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early detection of degraded A14-125I-insulin in human fibroblasts by the use of high performance liquid chromatography.
    Stentz FB; Harris HL; Kitabchi AE
    Diabetes; 1983 May; 32(5):474-7. PubMed ID: 6341131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Facile identification by electrospray mass spectrometry of the insulin fragment A14-21-B17-30 produced by insulin proteinase.
    Vu L; Stöcklin R; Rose K; Offord RE
    Rapid Commun Mass Spectrom; 1993 Nov; 7(11):1048-50. PubMed ID: 8280915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin binding, internalization, and degradation by a cultured kidney cell line.
    Yagil C; Ehmann UK; Frank BH; Rabkin R
    Am J Physiol; 1988 May; 254(5 Pt 1):E601-8. PubMed ID: 2834959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts.
    Stentz FB; Harris HL; Kitabchi AE
    Endocrinology; 1985 Mar; 116(3):926-34. PubMed ID: 3882399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term insulin-induced glycogen formation in primary hepatocytes as a screening bioassay for insulin action.
    Vu L; Pralong WF; Cerini F; Gjinovci A; Stöcklin R; Rose K; Offord RE; Kippen AD
    Anal Biochem; 1998 Aug; 262(1):17-22. PubMed ID: 9735143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism and degradation products of recombinant human insulin-like growth factor-I in lysosomes of rat kidney.
    Tanaka Y; Tamoto H; Tozuka Z; Sato A; Kimura T
    Xenobiotica; 1999 Mar; 29(3):281-95. PubMed ID: 10219968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic metabolism of insulin.
    Duckworth WC; Hamel FG; Peavy DE
    Am J Med; 1988 Nov; 85(5A):71-6. PubMed ID: 3057896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.